SRPT: Sarepta Therapeutics, Inc. Stock

by  •  • Comments Off on SRPT: Sarepta Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,567.46
Enterprise Value ($M) 4,464.88
Book Value ($M) 1,142.72
Book Value / Share 11.63
Price / Book 3.12
NCAV ($M) 109.87
NCAV / Share 1.12
Price / NCAV 32.47

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.08
Return on Equity (ROE) -0.26

Liquidity (mrq)
Quick Ratio 2.46
Current Ratio 4.02

Balance Sheet (mrq) ($M)
Current Assets 2,432.53
Assets 3,465.39
Liabilities 2,322.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,901.98
Operating Income 218.08
Net Income 235.24
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -205.79
Cash from Investing 755.56
Cash from Financing 124.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Capital International Investors 9.30 39.80
11-14 13G/A Janus Henderson Group Plc 4.60 -18.47
06-07 13G/A BlackRock, Inc. 10.70 61.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 1,026,492 6,200,401 16.56
2025-05-08 1,493,511 8,347,521 17.89
2025-05-07 3,656,189 18,572,802 19.69
2025-05-06 2,348,822 12,243,083 19.18
2025-05-05 437,569 1,647,599 26.56

(click for more detail)

Similar Companies
SLRN – Acelyrin, Inc. SNDX – Syndax Pharmaceuticals, Inc.
SPRO – Spero Therapeutics, Inc. SRRK – Scholar Rock Holding Corporation
STOK – Stoke Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io